Our mission is to advance and safeguard the interests of public sector employees, retirees, and their dependents by supporting their access to affordable, comprehensive, high-quality health care. Through the development of public policy research and analysis, we aim to raise awareness and advance the knowledge base on key issues impacting public sector purchasers and their health care plans.
To ensure we advance this mission, the Institute has outlined a plan with our strategic goals, approaches, and focus areas.
Strengthen the data and information environment by mapping public sector plans across the nation and supporting the establishment of an all-payer claims database
Develop evidence-based analyses and artifacts to fill gaps in research and to better understand the challenges public sector purchasers face when trying to uphold their fiduciary responsibilities.
Raise awareness and educate the Washington, D.C. policy community through public events and research on the key issues impacting health care plans available to public sector employees, retirees, and their beneficiaries.
Partner with key experts and stakeholders to disseminate our research and amplify our efforts to strategically identified audiences.
Monitor relevant issues in Congress and the Executive Branch for Institute members to support the development of public responses and inform their issue agendas.
The Institute will expand its data capabilities by exploring investing in an all-payer claims database and centralized data warehouse while continuing to develop state-specific profiles of the public sector purchaser landscape.
Improved landscape knowledge and data capabilities will bolster the Institute’s capacity to develop evidence-based research, reports, issue briefs, and other organizational materials across the core issue areas.
Each year, the Institute will publish the Specialty Drug Survey Report outlining public sector purchasers’ beneficiaries, spending, and contracting trends based on data collected the previous year. Additionally, the Institute will publish a minimum of two supplemental documents discussing the impact of topical policies on public sector purchasers and/or EGWPs. Research, analysis, artifacts, and issue briefs will focus on one of the Institute’s four core focus areas – data collection and analysis, pharmaceutical prices, EGWPs, and hospital consolidation and pricing.
Each year, the Institute will publish the Specialty Drug Survey Report outlining public sector purchasers’ beneficiaries, spending, and contracting trends based on data collected the previous year. Additionally, the Institute will publish a minimum of two supplemental documents discussing the impact of topical policies on public sector purchasers and/or EGWPs. Research, analysis, artifacts, and issue briefs will focus on one of the Institute’s four core focus areas – data collection and analysis, pharmaceutical prices, EGWPs, and hospital consolidation and pricing.
The Institute team will track, identify, and prepare congressional testimony on key committees including the Senate Finance, Senate Health, Education, Labor and Pensions (HELP), Senate Commerce, House Energy & Commerce, and House Ways & Means Committees.
The Institute will track legislation, proposed rules, and regulations that relate to our four focus areas and the impact on public sector purchasers. The Institute team will share policy developments at Executive Committee, Board of Directors, Industry Advisory Committee, and Membership meetings. Policy developments that require immediate attention will be directed to the Executive Director and other Executive Committee members as deemed appropriate.
Contribute research and education to the collection, analysis, and dissemination of spending- and cost-related data to equip public sector purchasers to coordinate amongst each other, determine policy priorities, and understand the landscape of federal policies.
Conduct research and analysis on the tools and practices public sector purchasers deploy to manage rising drug costs while preserving beneficiaries’ access to pharmaceutical products
Educate policymakers and other industry groups on the role of Employer Group Waiver Plans (EGWPs) in serving public sector employees, retirees, and their dependents.
Research and educate the public on the higher costs public sector employees, retirees, their dependents, and taxpayers pay as a result of anti-competitive practices.
The Institute’s founding members will provide the initial funding. The long-term sustainability of the Institute will depend on support from a growing base of stakeholders and supporters. The Board Treasurer, in collaboration with the Institute staff, will develop a budget and fundraising goals for the Board’s approval.
To support the Institute’s work, Executive Committee members and the Institute staff will recruit organizations, both public sector purchasers and corporate, to the Institute to gain access to its’ network, admission to events, and contribute to the dialogue on public sector employee health care.
The Institute staff in coordination with the Executive Director will provide policy, strategic planning, and communications support. After reaching the necessary funding levels, the Institute will explore hiring additional dedicated staff to provide full-time support.
National Institute for Public Employee Health Care Policy
601 Massachusetts Avenue
Suite 520W
Washington, DC 20001
Email: admin@healthcarepolicy-institute.org